MARY BLACK: Open Payments
NPI 1679051668 · CLINTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 15 payments from 7 companies in 2025. Trend: 2023 $57 · 2024 $221 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $134 |
| Melinta Therapeutics, LLC | 2 | $33 |
| Novo Nordisk Inc | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: BREZTRI, Kimyrsa, AIRSUPRA, Rybelsus, TRELEGY ELLIPTA, EVENITY, JARDIANCE, Jornay PM.
Industry payments across AR — which companies pay providers there.
